Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Note purchase agreement and consulting agreement with G FarmaLabs Limited: Schedule of Notes receivable from G Farma (Details)

v3.20.1
Note 8 - Note purchase agreement and consulting agreement with G FarmaLabs Limited: Schedule of Notes receivable from G Farma (Details) - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Details    
Real estate note $ 111,009 $ 111,009
Working capital note 934,042 934,042
Impairment recorded (1,045,051) (1,045,051)
Accrued interest 0 0
Long term portion of notes receivable $ 0 $ 0